Solazyme, Inc., which uses its industrial biotech platform to transform plant-based sugars into tailored oils, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The South San Francisco, CA-based company, which was founded in 2003 and booked $38 million in sales last year, plans to list on the NASDAQ under the symbol SZYM. Morgan Stanley and Goldman, Sachs & Co. are the lead underwriters on the deal, for which pricing terms and timing were not disclosed.
